New Leaders Appointed at CDC, FASEB


On July 7, Health and Human Services Secretary Tom Price announced that Brenda Fitzgerald had been selected as director of the Centers for Disease Control and Prevention (CDC).

Fitzgerald is an obstetrician-gynecologist who served as the commissioner of the Georgia Department of Public Health. In that capacity, Fitzgerald served on an advisory council on childhood obesity where she helped to develop public-private partnerships to address growing rates of the disease in the state of Georgia. The council’s program Georgia SHAPE launched in 2012 and has received more than $57 million to promote healthy eating and physical activity in the state. The program also encouraged elementary schools to incorporate 30 additional minutes of exercise.

The Endocrine Society looks forward to working with Fitzgerald to address critical public health issues like diabetes and obesity and to continue the work the agency has done to promote prevention programs nationwide.

Endocrine Society Congratulates New FASEB Executive Director

In July, Frank J. Krause, Jr, CAE, will join the Federation of American Societies for Experimental Biology (FASEB) as its new executive director. Krause joins FASEB after serving as the Chief Operating Officer of the American Geophysical Union (AGU), where his responsibilities included strategy, publications, meetings and talent pool programs, financial operations, and the technology and project management office.

The Society has been a FASEB member organization since 1999 and works with the Federation to address science policy issues on behalf of our members. As a FASEB member organization, we are part of a strong collective voice to more effectively advocate for biomedical researchers. Krause joins FASEB at a critical time; steady, sustainable increases for the National Institutes of Health are vitally important to endocrine researchers, and ongoing budget battles threaten to derail significant progress made over the past two years.

You may also like

  • NIDDK Releases Funding Opportunity Announcements for Type 1 Diabetes Research

    On February 15, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) released 17 long-awaited Funding Opportunity Announcements (FOAs) to support a variety of research projects related to type 1 diabetes and its complications. These FOAs are supported with the recent $150 million extension of the Special Statutory Funding Program for Type 1…

  • Special Diabetes Program In Jeopardy; Congress Needs to Hear from You

    As Congress readies itself for the next federal budget deadline (February 8), funding for the Special Diabetes Program (SDP) remains uncertain. A top priority for the Endocrine Society is funding the SDP, which includes the Special Type 1 Program that funds NIH research and the Special Diabetes Program for Indians that provides diabetes education and…

Find more in